SCHEMBL7340896

SCHEMBL7340896

Cc1c(-c2ccccc2)nc2ccccc2c1C(=O)NC(CCO)c1ccccc1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR3 P29371 20/20 0.80
TACR2 P21452 7/20 0.80
CYP1A2 P05177 2/20 0.80
CYP3A4 P08684 2/20 0.80
CYP2C9 P11712 2/20 0.80
CYP2C19 P33261 2/20 0.80
MEN1 O00255 1/20 0.80
ALDH1A1 P00352 1/20 0.80
TP53 P04637 1/20 0.80
TSHR P16473 1/20 0.80
NFKB1 P19838 1/20 0.80
MAPK1 P28482 1/20 0.80
BLM P54132 1/20 0.80
PMP22 Q01453 1/20 0.80
KMT2A Q03164 1/20 0.80
ATM Q13315 1/20 0.80
SMN1; SMN2 Q16637 1/20 0.80
HIF1A Q16665 1/20 0.80
FFAR4 Q5NUL3 1/20 0.80
NPSR1 Q6W5P4 1/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7342220 1.00 TACR3 (0.80) TACR3TACR2CYP1A2CYP3A4CYP2C9
SCHEMBL8800348 0.89 TACR3 (0.81) TACR3TACR2CYP1A2CYP3A4CYP2C9
SCHEMBL8800343 0.89 TACR3 (0.81) TACR3TACR2CYP1A2CYP3A4CYP2C9
Sb-222200 SCHEMBL6448819 0.89 TACR3 (1.00) TACR3TACR2CYP1A2CYP3A4CYP2C9
Sb-222200 SCHEMBL29407508 0.89 TACR3 (1.00) TACR3TACR2CYP1A2CYP3A4CYP2C9
Sb-222200 SCHEMBL3105312 0.89 TACR3 (1.00) TACR3TACR2CYP1A2CYP3A4CYP2C9
Sb-222200 SCHEMBL1580886 0.89 TACR3 (1.00) TACR3TACR2CYP1A2CYP3A4CYP2C9
SCHEMBL14567384 0.88 TACR3 (0.81) TACR3TACR2CYP1A2CYP3A4CYP2C9
SCHEMBL8199230 0.88 TACR3 (0.78) TACR3TACR2CYP1A2CYP3A4CYP2C9
SCHEMBL8199228 0.88 TACR3 (0.78) TACR3TACR2CYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1019377-A1 QUINOLINE-4-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS NEUROKININ 3 (NK-3)- AND NEUROKININ 2 (NK-2) RECEPTOR ANTAGONISTS. Smithkline Beecham S.p.A. (IT) 2000-07-19 EP disclosed
EP-0804419-A1 QUINOLINE DERIVATIVES AS TACHYKININ NK 3 RECEPTOR ANTAGONISTS SmithKline Beecham Farmaceutici S.p.A. (IT) 1997-11-05 EP disclosed
WO-1997019926-A1 QUINOLINE-4-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS NEUROKININ 3 (NK-3)- AND NEUROKININ 2 (NK-2) RECEPTOR ANTAGONISTS. SMITHKLINE BEECHAM S.P.A. (IT) 1997-06-05 WO disclosed
WO-1997019927-A1 QUINOLINE DERIVATIVES AS NK3 ANTAGONISTS SMITHKLINE BEECHAM S.P.A. (IT) 1997-06-05 WO disclosed